Increased epoxyeicosatrienoic acid formation in the rat kidney during liver cirrhosis

Journal of the American Society of Nephrology

Volumn 14, Issue 7, 2003, Pages 1766-1775

  Miyazono, Motoaki ^b   Zhu, Daling ^c   Nemenoff, Raphael ^a   Jacobs, Elizabeth R ^c   Carter, Ethan P ^a,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b SAGA UNIVERSITY   (Japan)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; ACETYLCHOLINE; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; HEPOXILIN B; NITRIC OXIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMMON BILE DUCT; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PERFUSION; LIVER CIRRHOSIS; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

EID: 0037530612     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000076074.63334.99     Document Type: Article

References (41)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J: Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151-1157, 1988
2. Gronich JH, Bonventre JV, Nemenoff RA: Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations. Biochem J 271: 37-43, 1990
3. Bonventre JV: Phospholipase A2 and signal transduction. J Am Soc Nephrol 3: 128-150, 1992
4. Clark JD, Milona N, Knopf JL: Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A 87: 7708-7712, 1990
5. Roman RJ: P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002
6. Capdevila JH, Falck JR, Harris RC: Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41: 163-181, 2000
7. Capdevila JH, Falck JR: The CYP P450 arachidonic acid mono-oxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 285: 571-576, 2001
8. Zeldin DC: Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062, 2001
9. Fleming I: Cytochrome p450 and vascular homeostasis. Circ Res 89: 753-762, 2001
10. Makita K, Falck JR, Capdevila JH: Cytochrome P450, the arachidonic acid cascade, and hypertension: New vistas for an old enzyme system. FASEB J 10: 1456-1463, 1996
11. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH: The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 104: 751-760, 1999
12. Karara A, Makita K, Jacobson HR, Falck JR, Guengerich FP, DuBois RN, Capdevila JH: Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J Biol Chem 268: 13565-13570, 1993
13. Asbert M, Gines A, Gines P, Jimenez W, Claria J, Salo J, Arroyo V, Rivera F, Rodes J: Circulating levels of endothelin in cirrhosis. Gastroenterology 104: 1485-1491, 1993
14. Tsai YT, Lin HC, Yang MC, Lee FY, Hou MC, Chen LS, Lee SD: Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J Hepatol 23: 681-688, 1995
15. Bernardi M, Gulberg V, Colantoni A, Trevisani F, Gasbarrini A, Gerbes AL: Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol 24: 161-168, 1996
16. Garcia-Estan J, Atucha NM, Sabio JM, Vargas F, Quesada T, Romero JC: Increased endothelium-dependent renal vasodilation in cirrhotic rats. Am J Physiol 267: R549-R553, 1994
17. Miyazono M, Garat CV, Morris KG Jr, Carter EP: Reduced heme oxygenase-1 expression contributes to renal vasoconstriction during cirrhosis. Am J Physiol Renal Physiol 283: F1123-F1131, 2002
18. Niederberger M, Gines P, Martin PY, St John J, Woytaszek P, Xu L, Tsai P, Nemenoff RA, Schrier RW: Increased renal and vascular cytosolic phospholipase A2 activity in rats with cirrhosis and ascites. Hepatology 27: 42-47, 1998
19. Zhu D, Effros RM, Harder DR, Roman RJ, Jacobs ER: Tissue sources of cytochrome P450 4A and 20-HETE synthesis in rabbit lungs. Am J Respir Cell Mol Biol 19: 121-128, 1998
20. Saito JM, Bostick MK, Campe CB, Xu J, Maher JJ: Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis. Hepatol Res 25: 180-191, 2003
21. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M: Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27: 855-865, 2000
22. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, Schwartzman ML: Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors. J Pharmacol Exp Ther 284: 966-973, 1998
23. Martin PY, Gines P, Schrier RW: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339: 533-541, 1998
24. Niederberger M, Gines P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW: Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus pre-hepatic portal hypertension in rats. Hepatology 24: 947-951, 1996
25. Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G: Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 26: 75-80, 1997
26. Imig JD, Falck JR, Wei S, Capdevila JH: Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res 38: 247-255, 2001
27. Quilley J, Fulton D, McGiff JC: Hyperpolarizing factors. Biochem Pharmacol 54: 1059-1070, 1997
28. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, Roman RJ: Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. Am J Physiol 270: F822-F832, 1996
29. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR: Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370, 1996
30. Dennis EA: The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22: 1-2, 1997
31. Chilton F: Would the real role(s) for secretory PLA2s please stand up. J Clin Invest 97: 2161-2162, 1996
32. Kramer RM, Sharp JD: Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett 410: 49-53, 1997
33. Katoh T, Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR, Badr KF: Glomerular stereospecific synthesis and hemodynamic actions of 8,9- epoxyeicosatrienoic acid in rat kidney. Am J Physiol 261: F578-F586, 1991
34. Ma J, Qu W, Scarborough PE, Tomer KB, Moomaw CR, Maronpot R, Davis LS, Breyer MD, Zeldin DC: Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem 274: 17777-17788, 1999
35. Omata K, Abraham NG, Schwartzman ML: Renal cytochrome P-450-arachidonic acid metabolism: Localization and hormonal regulation in SHR. Am J Physiol 262: F591-F599, 1992
36. McGiff JC, Quilley J: 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 10: 231-237, 2001
37. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, DuBois RN: Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267: 21720-21726, 1992
38. Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC: Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 104: 1131-1137, 1999
39. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH: Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 94: 2414-2420, 1994
40. Fang X, Kaduce TL, Weintraub NL, Van Rollins M, Spector AA: Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ Res 79: 784-793, 1996
41. Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997